{"count": 7, "results": [{"_id": "34271418", "pmid": 34271418, "title": "Metformin inhibits polyphosphate-induced hyper-permeability and inflammation.", "journal": "Int Immunopharmacol", "authors": ["Asgharzadeh F", "Barneh F", "Fakhraie M", "Adel Barkhordar SL", "Shabani M", "Soleimani A", "Rahmani F", "Ariakia F", "Mehraban S", "Avan A", "Hashemzehi M", "Arjmand MH", "Behnam-Rassouli R", "Jaberi N", "Sayyed-Hosseinian SH", "Ferns GA", "Ryzhikov M", "Jafari M", "Khazaei M", "Hassanian SM"], "date": "2021-10-01T00:00:00Z", "doi": "10.1016/j.intimp.2021.107937", "meta_date_publication": "2021 Oct", "meta_volume": "99", "meta_issue": "", "meta_pages": "107937", "score": 50273.156, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @CHEMICAL_Polyphosphates @CHEMICAL_MESH:D011122 @@@polyphosphate@@@-induced @<m>DISEASE_Job_Syndrome</m> @DISEASE_MESH:D007589 @@@hyper-permeability@@@ and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@.", "citations": {"NLM": "Asgharzadeh F, Barneh F, Fakhraie M, Adel Barkhordar SL, Shabani M, Soleimani A, Rahmani F, Ariakia F, Mehraban S, Avan A, Hashemzehi M, Arjmand MH, Behnam-Rassouli R, Jaberi N, Sayyed-Hosseinian SH, Ferns GA, Ryzhikov M, Jafari M, Khazaei M, Hassanian SM. Metformin inhibits polyphosphate-induced hyper-permeability and inflammation. Int Immunopharmacol. 2021 Oct;99():107937. PMID: 34271418", "BibTeX": "@article{34271418, title={Metformin inhibits polyphosphate-induced hyper-permeability and inflammation.}, author={Asgharzadeh F and Barneh F and Fakhraie M and Adel Barkhordar SL and Shabani M and Soleimani A and Rahmani F and Ariakia F and Mehraban S and Avan A and Hashemzehi M and Arjmand MH and Behnam-Rassouli R and Jaberi N and Sayyed-Hosseinian SH and Ferns GA and Ryzhikov M and Jafari M and Khazaei M and Hassanian SM}, journal={Int Immunopharmacol}, volume={99}, pages={107937}}"}}, {"_id": "37168843", "pmid": 37168843, "pmcid": "PMC10164964", "title": "Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells", "journal": "Front Aging", "authors": ["Abdelgawad IY", "Agostinucci K", "Sadaf B", "Grant MKO", "Zordoky BN"], "date": "2023-04-24T00:00:00Z", "doi": "10.3389/fragi.2023.1170434", "meta_date_publication": "2023", "meta_volume": "4", "meta_issue": "", "meta_pages": "1170434", "score": 50261.88, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ mitigates SASP secretion and @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@-triggered @<m>DISEASE_Job_Syndrome</m> @DISEASE_MESH:D007589 @@@hyper-@@@@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ in @CHEMICAL_Doxorubicin @CHEMICAL_MESH:D004317 @@@Doxorubicin@@@-induced senescent endothelial cells", "citations": {"NLM": "Abdelgawad IY, Agostinucci K, Sadaf B, Grant MKO, Zordoky BN. Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells Front Aging. 2023;4():1170434. PMID: 37168843", "BibTeX": "@article{37168843, title={Metformin mitigates SASP secretion and LPS-triggered hyper-inflammation in Doxorubicin-induced senescent endothelial cells}, author={Abdelgawad IY and Agostinucci K and Sadaf B and Grant MKO and Zordoky BN}, journal={Front Aging}, volume={4}, pages={1170434}}"}}, {"_id": "35905940", "pmid": 35905940, "title": "The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice.", "journal": "Biochim Biophys Acta Mol Basis Dis", "authors": ["Lyu Q", "Wen Y", "He B", "Zhang X", "Chen J", "Sun Y", "Zhao Y", "Xu L", "Xiao Q", "Deng H"], "date": "2022-11-01T00:00:00Z", "doi": "10.1016/j.bbadis.2022.166508", "meta_date_publication": "2022 Nov 1", "meta_volume": "1868", "meta_issue": "11", "meta_pages": "166508", "score": 50248.02, "text_hl": "Furthermore, @GENE_NFKB1 @GENE_18033 @@@NF-kappaB@@@ signaling pathway was involved in the anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. These findings suggest that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment may be conducive to the prevention of age-related @DISEASE_Sarcopenia @DISEASE_MESH:D055948 @@@sarcopenia@@@ by regulating @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ metabolism in skeletal muscle, i.e. enhanced lipolysis and attenuated @<m>DISEASE_Job_Syndrome</m> @DISEASE_MESH:D007589 @@@hyper@@@-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ responses, which may be AMPK-dependent processes. ", "citations": {"NLM": "Lyu Q, Wen Y, He B, Zhang X, Chen J, Sun Y, Zhao Y, Xu L, Xiao Q, Deng H. The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice. Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166508. PMID: 35905940", "BibTeX": "@article{35905940, title={The ameliorating effects of metformin on disarrangement ongoing in gastrocnemius muscle of sarcopenic and obese sarcopenic mice.}, author={Lyu Q and Wen Y and He B and Zhang X and Chen J and Sun Y and Zhao Y and Xu L and Xiao Q and Deng H}, journal={Biochim Biophys Acta Mol Basis Dis}, volume={1868}, number={11}, pages={166508}}"}}, {"_id": "33982074", "pmid": 33982074, "title": "Metformin acts to suppress beta-hydroxybutyric acid-mediated inflammatory responses through activation of AMPK signaling in bovine hepatocytes.", "journal": "J Anim Sci", "authors": ["Xu T", "Lu X", "Arbab AAI", "Wu X", "Mao Y", "Loor JJ", "Yang Z"], "date": "2021-07-01T00:00:00Z", "doi": "10.1093/jas/skab153", "meta_date_publication": "2021 Jul 1", "meta_volume": "99", "meta_issue": "7", "meta_pages": "", "score": 50243.406, "text_hl": "The occurrence of @SPECIES_9913 @@@bovine@@@ @DISEASE_Ketosis @DISEASE_MESH:D007662 @@@ketosis@@@ involves the accumulation of @CHEMICAL_3_Hydroxybutyric_Acid @CHEMICAL_MESH:D020155 @@@beta-hydroxybutyric acid@@@ (@CHEMICAL_3_Hydroxybutyric_Acid @CHEMICAL_MESH:D020155 @@@BHBA@@@), which contributes to the initiation and acceleration of hepatic metabolic stress and @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has other beneficial effects apart from its medical intervention for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, such as prevention of laminitis and @<m>DISEASE_Job_Syndrome</m> @DISEASE_MESH:D007589 @@@hyper-triglyceridemic@@@. ", "citations": {"NLM": "Xu T, Lu X, Arbab AAI, Wu X, Mao Y, Loor JJ, Yang Z. Metformin acts to suppress beta-hydroxybutyric acid-mediated inflammatory responses through activation of AMPK signaling in bovine hepatocytes. J Anim Sci. 2021 Jul 1;99(7):. PMID: 33982074", "BibTeX": "@article{33982074, title={Metformin acts to suppress beta-hydroxybutyric acid-mediated inflammatory responses through activation of AMPK signaling in bovine hepatocytes.}, author={Xu T and Lu X and Arbab AAI and Wu X and Mao Y and Loor JJ and Yang Z}, journal={J Anim Sci}, volume={99}, number={7}}"}}, {"_id": "25098041", "pmid": 25098041, "title": "Effect of metformin hydrochloride in correcting hyperinsulinemia and high leptin levels in treatment of infertile polycystic patients.", "journal": "J Ayub Med Coll Abbottabad", "authors": ["Irfan A", "Mughal IA", "Jalali S"], "date": "2013-01-01T00:00:00Z", "meta_date_publication": "2013 Jan-Jun", "meta_volume": "25", "meta_issue": "1-2", "meta_pages": "8-11", "score": 50054.07, "text_hl": "Another aim was to assess the decrease in @<m>DISEASE_Job_Syndrome</m> @DISEASE_MESH:D007589 @@@hyper-insulinemia@@@ and @GENE_LEP @GENE_3952 @@@Leptin@@@ levels by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Glucophage@@@ in our population. ", "citations": {"NLM": "Irfan A, Mughal IA, Jalali S. Effect of metformin hydrochloride in correcting hyperinsulinemia and high leptin levels in treatment of infertile polycystic patients. J Ayub Med Coll Abbottabad. 2013 Jan-Jun;25(1-2):8-11. PMID: 25098041", "BibTeX": "@article{25098041, title={Effect of metformin hydrochloride in correcting hyperinsulinemia and high leptin levels in treatment of infertile polycystic patients.}, author={Irfan A and Mughal IA and Jalali S}, journal={J Ayub Med Coll Abbottabad}, volume={25}, number={1-2}, pages={8-11}}"}}, {"_id": "10598343", "pmid": 10598343, "title": "[Diagnosis and treatment of polycystic ovary syndrome].", "journal": "J Gynecol Obstet Biol Reprod (Paris)", "authors": ["Gandar R", "Spizzo M", "Collin D"], "date": "1999-10-01T00:00:00Z", "meta_date_publication": "1999 Oct", "meta_volume": "28", "meta_issue": "6", "meta_pages": "510-8", "score": 50035.637, "text_hl": "Subsequent to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration, the reduction of @DISEASE_Hyperinsulinism @DISEASE_MESH:D006946 @@@hyper I@@@ and androgen serum levels creates a favorable condition for the resumption of ovarian function and @CHEMICAL_Clomiphene @CHEMICAL_MESH:D002996 @@@clomiphene citrate@@@ action. ", "citations": {"NLM": "Gandar R, Spizzo M, Collin D. [Diagnosis and treatment of polycystic ovary syndrome]. J Gynecol Obstet Biol Reprod (Paris). 1999 Oct;28(6):510-8. PMID: 10598343", "BibTeX": "@article{10598343, title={[Diagnosis and treatment of polycystic ovary syndrome].}, author={Gandar R and Spizzo M and Collin D}, journal={J Gynecol Obstet Biol Reprod (Paris)}, volume={28}, number={6}, pages={510-8}}"}}, {"_id": "27898267", "pmid": 27898267, "title": "Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.", "journal": "Gynecol Endocrinol", "authors": ["Monastra G", "Unfer V", "Harrath AH", "Bizzarri M"], "date": "2017-01-01T00:00:00Z", "doi": "10.1080/09513590.2016.1247797", "meta_date_publication": "2017 Jan", "meta_volume": "33", "meta_issue": "1", "meta_pages": "1-9", "score": 50034.39, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@-sensitizing drugs, such as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, are effective in treating @<m>DISEASE_Job_Syndrome</m> @DISEASE_MESH:D007589 @@@hyper-insulinemic@@@ @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@PCOS@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Monastra G, Unfer V, Harrath AH, Bizzarri M. Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecol Endocrinol. 2017 Jan;33(1):1-9. PMID: 27898267", "BibTeX": "@article{27898267, title={Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.}, author={Monastra G and Unfer V and Harrath AH and Bizzarri M}, journal={Gynecol Endocrinol}, volume={33}, number={1}, pages={1-9}}"}}]}